Literature DB >> 21517929

Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.

S Oak1, J Radtke, C Törn, M Landin-Olsson, C S Hampe.   

Abstract

Previously we reported the presence of anti-idiotypic antibodies (anti-Id)-specific to autoantibodies against GAD65 (GAD65Ab) in healthy individuals while the activity of anti-Id directed to GAD65Ab in type 1 diabetes (T1D) patients was significantly lower. These anti-Id recognize the antigen-binding site of GAD65Ab, thus preventing their binding to GAD65. Here, we characterized the IgG subclass profile of these anti-Id (GAD65Ab specific) and of the associated GAD65Ab themselves. The IgG subclass response of anti-Id in healthy individuals (n = 16) was IgG3-dominated, while in T1D patients (n = 8) IgG1 was the major IgG subclass. The GAD65Ab bound by anti-Id in both healthy individuals (n = 38) and GAD65Ab-negative T1D patients (n = 35) showed a predominant rank order of IgG1 > IgG2 > IgG4 > IgG3. However, the frequency of GAD65Ab of the IgG4 subclass was significantly higher in T1D patients (P < 0.05). We conclude that the IgG subclass profile of anti-Id (GAD65Ab specific) in healthy individuals differs from that in T1D patients. These differences may provide insights into the development of these antibodies.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517929      PMCID: PMC3855415          DOI: 10.1111/j.1365-3083.2011.02565.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  29 in total

1.  Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules.

Authors:  B Bogen; B Malissen; W Haas
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

2.  IgG4 as a blocking antibody.

Authors:  R C Aalberse; P H Dieges; V Knul-Bretlova; P Vooren; M Aalbers; J van Leeuwen
Journal:  Clin Rev Allergy       Date:  1983-06

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.

Authors:  R L Rubin; F L Tang; A H Lucas; H L Spiegelberg; E M Tan
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

5.  Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.

Authors:  Carolyn J Padoa; J Paul Banga; Anne-Marie Madec; Manfred Ziegler; Michael Schlosser; Eva Ortqvist; Ingrid Kockum; Jerry Palmer; Olov Rolandsson; Katherine A Binder; Jefferson Foote; Dong Luo; Christiane S Hampe
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

6.  Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response.

Authors:  John G Routsias; Eleni Dotsika; Eugenia Touloupi; Maria Papamattheou; Constantinos Sakarellos; Maria Sakarellos-Daitsiotis; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  J Autoimmun       Date:  2003-08       Impact factor: 7.094

7.  Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

Authors:  R A Eisenberg; K Dyer; S Y Craven; C R Fuller; W J Yount
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

8.  MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production.

Authors:  Ludvig A Munthe; Audun Os; Michael Zangani; Bjarne Bogen
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

9.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  2 in total

1.  Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV?

Authors:  Gloria Preston; Ronald Falk
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

Review 2.  Advances in the cellular immunological pathogenesis of type 1 diabetes.

Authors:  Min Li; Lu-Jun Song; Xin-Yu Qin
Journal:  J Cell Mol Med       Date:  2014-03-14       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.